In today’s Health Alert, there’s a new way to protect yourself and your family from the flu this season - without leaving the house.  It’s called FluMist Home.

The split between the AAP and the federal government highlights growing tensions in public health policy under the Trump administration, particularly following controversial changes introduced by Health Secretary Robert F.

FluMist Home is an influenza vaccine that’s administered via nasal spray, which means no needles and no waiting in line at the pharmacy. Plus, it’s covered by insurance and experts say it’s about as effective as the traditional flu vaccine. But there’s a catch: It’s only been approved for people ages 2 to 49.

Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at pharmaceutical giants Eli Lilly and Pfizer that anti-vaccine activist Robert F.

Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, inevitable infectious diseases crisis rears its ugly head."

(Reuters) -Conflicts of interest on the U.S. Centers for Disease Control and Prevention’s vaccine advisory committee were at historic lows around the time when Health Secretary Robert F. Kennedy Jr. fired all 17 members in June, new data published in a medical journal on Monday showed.

Australian biotech CSL, the country's fourth-largest company, said on Tuesday it would spin off its vaccine division and shed about 3,000 employees as it reels from "unprecedented volatility," sending its shares tumbling.